Westchester Medical Center

Running trials

• Recruiting

  INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

  NCT06965504· Abiomed Inc.· Source

• Recruiting

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· Phase 3· Inhibikase Therapeutics· Source

• Recruiting

  Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  NCT07195591· Phase 3· GT Medical Technologies, Inc.· Source

• Recruiting

  Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

  NCT06935591· Vektor Medical· Source

• Not yet recruiting

  Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors

  NCT07000019· New York Medical College· Source

• Recruiting

  Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia

  NCT07814079· New York Medical College· Source

• Recruiting

  Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

  NCT06182397· Concept Medical Inc.· Source

• Active, not recruiting

  A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

  NCT06662383· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Cognition and Imaging With Tigertriever

  NCT05531461· Rapid Medical· Source

• Recruiting

  A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  NCT06623422· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

  NCT06399705· Phase 3· Weill Medical College of Cornell University· Source

• Recruiting

  REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

  NCT06399692· Phase 3· Weill Medical College of Cornell University· Source

• Recruiting

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· Phase 3· Pfizer· Source

• Recruiting

  Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  NCT05946213· Phase 3· NRG Oncology· Source

• Enrolling by invitation

  Evaluation of the GORE® Ascending Stent Graft

  NCT05800743· W.L.Gore & Associates· Source

• Recruiting

  Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  NCT05673148· Phase 2· Alliance for Clinical Trials in Oncology· Source

• Active, not recruiting

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· Phase 3· Cytokinetics· Source

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Johns Hopkins University· Source

• Recruiting

  Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  NCT05624996· Phase 3· NRG Oncology· Source

• Active, not recruiting

  A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors

  NCT05848739· Phase 1· Sapience Therapeutics· Source

• Active, not recruiting

  A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

  NCT04485949· Phase 2· Imvax· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

  NCT05378347· Medtronic Cardiovascular· Source

• Active, not recruiting

  Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

  NCT05360446· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

  NCT05338697· Yale University· Source

• Active, not recruiting

  Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

  NCT05317416· Phase 3· Pfizer· Source

• Active, not recruiting

  Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

  NCT05050084· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

  NCT04994132· Phase 3· Children's Oncology Group· Source

• Active, not recruiting

  US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair

  NCT04852783· Phase 4· Cerus Endovascular, Inc.· Source

• Enrolling by invitation

  Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

  NCT04848506· Phase 2/3· Cytokinetics· Source

• Active, not recruiting

  Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

  NCT04513717· Phase 3· NRG Oncology· Source

• Active, not recruiting

  A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

  NCT04072458· Phase 1· Bio-Path Holdings, Inc.· Source

• Recruiting

  Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  NCT04423211· Phase 3· ECOG-ACRIN Cancer Research Group· Source

• Recruiting

  Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  NCT04427384· GT Medical Technologies, Inc.· Source

• Active, not recruiting

  Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

  NCT04241185· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  NCT03907046· Phase 3· Yale University· Source

• Active, not recruiting

  Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

  NCT04095364· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

  NCT03914612· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Destination Therapy Post Approval Study

  NCT03681210· Medtronic Cardiac Rhythm and Heart Failure· Source

• Active, not recruiting

  Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

  NCT03180268· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  NCT02567435· Phase 3· National Cancer Institute (NCI)· Source

• Recruiting

  A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  NCT01351545· Center for International Blood and Marrow Transplant Research· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke5 recruiting
• Atrial fibrillation3 recruiting
• Aortic aneurysm2 recruiting
• Childhood cancers2 recruiting
• Coronary artery disease2 recruiting
• Glioblastoma2 recruiting
• Heart failure2 recruiting
• Lung cancer2 recruiting
• Peripheral artery disease2 recruiting
• Prostate cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Aplastic anaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Colorectal cancer1 recruiting
• High blood pressure1 recruiting
• Hodgkin lymphoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Meningioma1 recruiting
• Multiple myeloma1 recruiting
• Obesity1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Ventricular tachycardia1 recruiting

Closed trials

• Recruiting

  A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  NCT06570798· Phase 2· Amgen· Source

• Recruiting

  Strategy for Improving Stroke Treatment Response

  NCT05948566· Phase 2· Translational Sciences, Inc.· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Terminated

  The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output

  NCT05629533· Nanowear Inc.· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Bayer· Source

• Completed

  Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

  NCT05479812· Phase 1· Werewolf Therapeutics, Inc.· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· Phase 3· Cytokinetics· Source

• Terminated

  RNS System RESPONSE Study

  NCT04839601· NeuroPace· Source

• Completed

  realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

  NCT04981795· Incyte Corporation· Source

• Completed

  SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

  NCT03876457· University Hospitals Cleveland Medical Center· Source

• Completed

  A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

  NCT03642639· Cerenovus, Part of DePuy Synthes Products, Inc.· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· CSL Behring· Source

Trial sites

• Westchester Medical Center5 trials
• Westchester Medical Center2 trials
• 8400726 - Westchester Medical Center1 trial
• New York Medical College / Westchester Medical Center1 trial
• Westchester Medical Center48 trials
• Westchester Medical Center / New York Medical College1 trial
• Westchester Medical Center (Site 0196)1 trial
• Westchester Medical Center (Site 6014)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Hypertrophic cardiomyopathy15 works · 3 trials
• Congenital heart disease13 works · 0 trials
• Myocarditis8 works · 0 trials